Related Experiment Videos
A unique growth factor in patients with acromegaloidism
The Journal of Clinical Endocrinology and Metabolism
|August 1, 1983
Summary
Researchers identified a novel growth factor in the serum of patients with acromegaloidism, a condition mimicking acromegaly. This factor stimulates erythroid progenitor cells, even those unresponsive to growth hormone (GH).
Area of Science:
- Endocrinology
- Hematology
- Molecular Biology
Background:
- Acromegaloidism presents with acromegaly features but lacks elevated growth hormone (GH) or somatomedin levels.
- The underlying cause of acromegaloidism remains unclear, prompting investigation into potential novel growth factors.
Observation:
- Serum from acromegaloidism patients significantly enhanced human erythroid progenitor colony formation in vitro compared to normal serum.
- Chromatographic analysis of acromegaloidism serum revealed a growth-promoting factor with an estimated molecular weight of 70,000 daltons.
- This unidentified factor stimulated erythroid progenitor cells from a Laron dwarf, which were unresponsive to human GH.
Findings:
- A previously unknown growth factor is present in the serum of individuals with acromegaloidism.
- This factor exhibits potent stimulatory effects on erythroid progenitor cell growth.
- The factor's activity is distinct from known growth factors like EGF, NGF, FGF, and PDGF.
Implications:
- This discovery may offer new insights into the pathophysiology of acromegaloidism.
- The identified growth factor could represent a novel therapeutic target for certain hematological conditions.
- Further research is needed to elucidate the factor's physiological role in normal individuals and its pathogenic role in acromegaloidism.